AstraZeneca Loses $12.9M AWP Appeal
Responding to a “panoply of challenges” by AstraZeneca, the U.S. Court of Appeals for the First Circuit found that the trial court ruled without committing material legal error, abusing its discretionary power or making clear errors in its fact-finding, it said in a 98-page opinion issued Wednesday.
Judge Jeffrey Howard, who...
Already a subscriber? Click here to login